22.10.2025
... Umsatz weniger zu als gedacht Novartis - Cosentyx erfüllt primäre ...
20.10.2025
... seiner Kosmetiksparte an L'Oréal Novartis-Therapie Pluvicto verlängert Zeit ...
18.10.2025
... 05%, MorphoSys 0%, Fresenius -0,13%, Novartis -0,71%, Pfizer -1,09%, Merck ... BB Biotech 9,08% , Amgen 7,8% , Novartis 7,58% , Evotec 6,93% , Merck KGaA ...
18.10.2025
... %, Mercedes-Benz Group 0,32%, Novartis -0,71%, Pfizer -1,09%, Cisco ... 9,5% , IBM 9,23% , voestalpine 7,83% , Novartis 7,58% , ams-Osram 6,13% , Mercedes ...
11.10.2025
... 1,15%, Linde 0,05%, MorphoSys 0%, Novartis -0,25%, Amgen -0,66%, Evotec -0,68 ... , Amgen 5,44% , Sanofi 3,18% , Novartis 2,84% , Merck Co. 1,63% , Linde ...
11.10.2025
... 0,56%, Zumtobel -0,25%, Novartis -0,25%, Alphabet -1,71%, voestalpine ... Alphabet 3,44% , Sanofi 3,18% , Novartis 2,84% , Mercedes-Benz Group 2,8% , ...